An official website of the United States government
NIH Guide: Weekly Index for August 11, 2023
Weekly NIH Funding Opportunities and Notices
August 11, 2023
General Notices
-
NIDCR Notice of Participation in PAR-23-182 "Accelerating Behavioral and Social Science Through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed)"
(NOT-DE-23-015)National Institute of Dental and Craniofacial Research
-
Notice of Pre-Application Webinar for the Investigator-Initiated Research in Genomics and Health Equity: RFA-HG-23-017 (R01 Clinical Trial Optional) and RFA-HG-23-018 (R21 Clinical Trial Optional)
(NOT-HG-23-049)National Human Genome Research Institute
-
Notice of Availability: Proposed Amendments to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines)
(NOT-OD-23-162)Office of the Director, NIH
Notice of Changes to Funding Opportunities
-
Notice of Change to Application Due Date and Instruction in Section IV in RFA-DA-24-007, "Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)"
(NOT-DA-23-032)National Institute on Drug Abuse
-
Notice of NICHD Participation in PAR-23-122: "Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)"
(NOT-HD-23-024)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Changes to RFA-HL-24-010 "The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional)"
(NOT-HL-23-101)National Heart, Lung, and Blood Institute
-
Notice of Change to RFA-HL-24-011 "The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed)"
(NOT-HL-23-105)National Heart, Lung, and Blood Institute
-
Notice of Early Termination of PAR-21-057 "Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
(NOT-NS-23-103)National Institute of Neurological Disorders and Stroke
-
Notice of Early Termination of PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
(NOT-NS-23-104)National Institute of Neurological Disorders and Stroke
-
Notice of Change to Award Budget for RFA-NS-21-029, "HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)
(NOT-NS-23-105)National Institute of Neurological Disorders and Stroke
-
Notice of Correction to Other Submission Requirements and Information in PAR-22-181 "Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
(NOT-NS-23-106)National Institute of Neurological Disorders and Stroke
Notices of Special Interest
-
Notice of Special Interest (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established cohorts (R01 Clinical Trial Optional)
(NOT-HL-23-102)National Heart, Lung, and Blood Institute
Funding Opportunities
-
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
(PAR-23-229)National Institute on Drug AbuseNational Institute on Alcohol Abuse and AlcoholismNational Cancer InstituteNational Institute of Environmental Health SciencesNational Institute of Mental HealthOffice of Research on Women's HealthOffice of Behavioral and Social Sciences ResearchNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): Multiple dates, see announcement.
-
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
(PAR-23-242)National Cancer InstituteApplication Receipt Date(s): November 3, 2025
-
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
(PAR-23-243)National Cancer InstituteApplication Receipt Date(s): November 3, 2025
-
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
(PAR-23-245)National Library of MedicineNational Institute of Mental HealthApplication Receipt Date(s): November 5, 2026
-
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
(PAR-23-249)National Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): September 7, 2026
-
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
(PAR-23-250)National Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): September 7, 2026
-
Alcohol Health Services Research (R01 Clinical Trial Optional)
(PAR-23-251)National Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): September 7, 2026
-
Alcohol Health Services Research (R34 Clinical Trial Optional)
(PAR-23-252)National Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): September 7, 2026
-
Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)
(PAR-23-256)National Center for Complementary and Integrative HealthNational Institute on AgingApplication Receipt Date(s): Multiple dates, see announcement.
-
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
(PAR-23-259)National Cancer InstituteApplication Receipt Date(s): January 7, 2027
-
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
(PAR-23-264)National Cancer InstituteApplication Receipt Date(s): September 7, 2026
-
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
(PAR-23-273)National Cancer InstituteApplication Receipt Date(s): May 7, 2026
-
Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R01 Clinical Trial Not Allowed)
(RFA-AG-24-028)National Institute on AgingApplication Receipt Date(s): November 3, 2023
-
Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R21 Clinical Trial Not Allowed)
(RFA-AG-24-029)National Institute on AgingApplication Receipt Date(s): November 3, 2023
-
Neural and Non-Neural Mechanisms Underlying Gait as a Preclinical Marker for Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional)
(RFA-AG-24-041)National Institute on AgingApplication Receipt Date(s): November 03, 2023
-
Elucidating Variability of Physiologic and Functional Responses to Exercise Training in Older Adults (R01 Clinical Trial Required)
(RFA-AG-24-045)National Institute on AgingApplication Receipt Date(s): November 3, 2023
-
Community-Engaged Health Equity Research in Neuroscience Initiative (R01 CT Not Allowed)
(RFA-NS-24-006)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): February 2, 2024
-
Community-Engaged Health Equity Research in Neuroscience Initiative (R34 CT Not Allowed)
(RFA-NS-24-007)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional)
(RFA-NS-24-021)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: October 11, 2024
For technical issues E-mail OER Webmaster